The impact of SGLT2 inhibitors on renal outcomes in patients with type 2 diabetes and chronic kidney disease: systematic review and meta-analysis.

Front Endocrinol (Lausanne) · 2026 · PMC13152785 · PMID 42109728

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

did not reach statistical significanceP = 0.09so close (0.05 < p ≤ 0.1)

The results showed that the risk in the SGLT2 inhibitor group was slightly lower than that in the control group (OR = 0.88, 95% CI: 0.75 - 1.02), but did not reach statistical significance (P = 0.09).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.